Uwe Wollein

Identification of new synthetic PDE-5 inhibitors analogues found as minor components in a dietary supplement.

W. Eisenreich, N. Schramek, Uwe Wollein, 2014, Journal of pharmaceutical and biomedical analysis.

Potential metal impurities in active pharmaceutical substances and finished medicinal products - A market surveillance study.

N. Schramek, Uwe Wollein, R. Habernegg, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Identification of novel sildenafil-analogues in an adulterated herbal food supplement.

W. Eisenreich, N. Schramek, Uwe Wollein, 2011, Journal of pharmaceutical and biomedical analysis.

Determination and quantitation of sildenafil and its major metabolite in the breast milk of a lactating woman.

N. Schramek, J. Hardt, Uwe Wollein, 2016, Journal of pharmaceutical and biomedical analysis.

International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

P. Keizers, D. Keire, A. Zmyslowski, 2022, The AAPS Journal.

The Gramine Route to Pyrido[4,3-b]indol-3-ones – Identification of a New Cytotoxic Lead

F. Bracher, Uwe Wollein, 2010, Scientia pharmaceutica.

Pyrazolopyrimidines in ‘all-natural’ products for erectile dysfunction treatment: the unreliable quality of dietary supplements

W. Eisenreich, N. Schramek, Uwe Wollein, 2015, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

Simultaneous determination of alkyl mesilates and alkyl besilates in finished drug products by direct injection GC/MS.

N. Schramek, Nicholas Schramek, Uwe Wollein, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.